General Information of the Compound
Compound ID
CP0061303
Compound Name
(2R)-2-[(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]propanamido]acetamido}-3-phenylpropanamido]-4-methylpentanoic acid
    Show/Hide
Synonyms
(2R)-2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoic acid
(2R,5S,11R,14S)-14-Amino-5-benzyl-15-(4-hydroxyphenyl)-2-isobutyl-11-methyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazapentadecan-1-oic acid
(D-Ala2,D-Leu5)-Enkephalin
63631-40-3
AC1OCEJN
BW-180C
CHEMBL340032
DADL
DADLE
DADLE-OH
Dadle
H-TYR-D-ALA-GLY-PHE-D-LEU-OH
H-Tyr-D-Ala-Gly-Phe-D-Leu
HB4QD9GL6F
Tyr-D-Ala-Gly-Phe-D-Leu
UNII-HB4QD9GL6F
ZINC14952092
[D-Ala2, D-Leu5]-enkephalin
    Show/Hide
Structure
Formula
C29H39N5O7
Molecular Weight
569.659
Canonical SMILES
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O
    Show/Hide
InChI
InChI=1S/C29H39N5O7/c1-17(2)13-24(29(40)41)34-28(39)23(15-19-7-5-4-6-8-19)33-25(36)16-31-26(37)18(3)32-27(38)22(30)14-20-9-11-21(35)12-10-20/h4-12,17-18,22-24,35H,13-16,30H2,1-3H3,(H,31,37)(H,32,38)(H,33,36)(H,34,39)(H,40,41)/t18-,22+,23+,24-/m1/s1
    Show/Hide
InChIKey
ZHUJMSMQIPIPTF-IBURTVSXSA-N
Physicochemical Property
logP
0.2259
Rotatable Bonds
15
Heavy Atom Count
41
Polar Areas
199.95
Hydrogen Bond Donor Count
7
Hydrogen Bond Acceptor Count
7
Complexity
41

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 6917707
SID: 14813091
ChEMBL ID
CHEMBL340032
DrugBank ID
DB08856
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01200, Delta-type opioid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000026 CHO-K1 Cricetulus griseus (Chinese hamster)  1
1
EC50 = 0.02 nM
   TI
   LI
   LO
   TS
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 54 nM
   TI
   LI
   LO
   TS
CL000661 HN9.10e Mus musculus (Mouse)  1
1
Ki = 1.3 nM
   TI
   LI
   LO
   TS
Protein ID: PT01515, Mu-type opioid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 1300 nM
   TI
   LI
   LO
   TS
Protein ID: PT01549, Mu-type opioid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000661 HN9.10e Mus musculus (Mouse)  1
1
Ki = 15 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Kd = 0.9 nM
2 Kd = 22 nM
Clinical Information about the Compound
Drug 1 ( DADLE )
Drug Name DADLE
Target(s)
Opioid receptor mu (MOP)
Inhibitor
Opioid receptor delta (OPRD1)
Agonist